Survival and Problems after Repair of Tetralogy of Fallot.
- Author:
Se Jung SON
1
;
Jae Jin HAN
;
Young Thak LEE
;
Sung Ho KIM
Author Information
1. Department of Pediatrics, Ewha Womans University, College of Medicine.
- Publication Type:Original Article
- Keywords:
Tetralogy of Fallot;
Reoperation;
Survival
- MeSH:
Catheterization;
Catheters;
Echocardiography;
Follow-Up Studies;
Freedom;
Hospitals, General;
Humans;
Incidence;
Korea;
Mortality;
Reoperation;
Retrospective Studies;
Survival Rate;
Tetralogy of Fallot*;
Ventricular Dysfunction
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1999;32(3):237-248
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The late results of repair of tetralogy of Fallot(TOF) are favorable in most patients. Some portion of the patients with tetralogy, however, require reoperation for residual lesions or result in late death. The outcome of patients after tetralogy repair performed during the past 13 years was studied, with an emphasis on postrepair survival and problems including reoperations. MATERIAL AND METHOD: A retrospective review of clinical, echocardiographic and catheterization data was performed in 569 of 775 patients with TOF who underwent corrective repair between 1983 and 1995 at Sejong General Hospital, Buchon, Korea. RESULT: Of 28(4.9%) early deaths(defined as 30 days postrepair), 12 deaths(42.9%) were <1 year of age, with an operative mortality of 15.4%. The surviving 541 patients(age 2.8 months to 43.4 years, median 23 months) have been followed up from 1 month to 12.6 years(median 35 months) postoperatively. Most patients were in good functional class and had normal right ventricular(RV) function. Postrepair results were compared between the transatrial-transpulmonary approach and the conventional right ventriculotomy. The former technique provided a lesser incidence of significant pulmonary regurgitation(p<0.001) and alesser degree of RV dysfunction(p<0.05) compared with those in the latter. There were 10(1.8%) late deaths during the follow-up period and 6 of the deaths were directly related to reoperation or ventricular dysfunction. The 10-year actuarial survival rate was 96.7%. There were 44 reoperations(8.1%) in 39 patients(7.2%), with an operative mortality of 10.3%. The main indications or reoperation included residual ventricular septal defect(VSD) (n=6), pulmonary stenosis(PS) (n=11), VSD with PS(n=17), pulmonary regurgitation(n=7), and tricuspid regurgitation(n=2). The 5- and 10-year freedom from reoperation were 89.4% and 76.1%, respectively. CONCLUSION: Although the majority of patients with repaired TOF are clinically well, with a high rate of survival, approximately 7% of patients have residual lesions that require surgical therapy. Therefore, the timely and meticulous corrective repair is mandatory to avoid reoperation, and continued close surveillance is also needed for the early detection of residual problems.
